41 articles, transcripts, and reports
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%. Fourth-quarter…
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based marketplace for integrated…
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q3 2021 earnings call dated Oct. 25, 2021 Corporate Participants: Howard Doss — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen…
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the US, account for…
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2021 earnings call dated Jul. 26, 2021 Corporate Participants: Howard Doss — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen…
Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare services at affordable prices, mainly…
Trxade Group Inc. (NASDAQ: MEDS) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Howard Doss — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen…
Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra Pharma Solutions unit.…
With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced its commitment to developing a…
Trxade Group, Inc. (NASDAQ: MEDS) Q4 2020 earnings call dated Mar. 29, 2021 Corporate Participants: Howard Doss — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen…
